If you have been reading about Lipodystrophy and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Located on pituitary somatotroph cells |
| Signaling route | cAMP–protein kinase A | Gs-coupled receptor pathway |
| Downstream markers | Growth hormone and IGF-1 | Used as pharmacodynamic readouts |
| Common detection | LC-MS/MS | Separates intact peptide from fragments |
| Typical storage | 2–8 °C, protected from light | Applies to solid form before reconstitution |
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
=== 2020 === In June 2021, the company continued with acquisitions for polyolefin catalysts business units and acquired the polyolefin catalysts unit of Albemarle Corporation for $416 million. Grace stated that "the deal will strengthen its position in single-site and metallocene catalysts for polyolefins and Ziegler-Natta catalysts for polyethylene." In September 2021, Standard Industries acquired the company. Standard Industries purchased the company for $70 per share, which was approximately a $7 billion transaction at that time. In September 2022, Saint-Gobain announced the acquisition of GCP Applied Technologies for $32.00 per share, in cash, or approximately $2.3 billion for the purchase. With the transaction, GCP was delisted from the stock exchange.
Due to the rapid increase in COVID-19 cases across the country, the CBSE cancelled the 10th class board exams and postponed the 12th class exams. Like the 10th, Class 12th Board Exam 2021 has also been cancelled. Prime Minister Narendra Modi decided on this after a long meeting on 1 June 2021. Later, in a letter dated 5 July 2021, CBSE announced a special assessment scheme for the board examinations of classes X and XII for the session 2021–22. The academic year was divided into two terms, with approximately 50% of the syllabus in each, to increase the likelihood that the CBSE would conduct boards and avoid relying on schools to declare results. The Term 1 examination was successfully conducted by CBSE in objective mode from 22 November to 12 December 2021 for Class 10 and from 16 November to 30 December 2021 for Class 12. However, the Term-I examination was criticised by many for having wrong answer keys, tough question papers and wrong or controversial questions, with a question being dropped in Sociology exam of class 12 and a paragraph in the English Language and Literature exam for class 10 by CBSE following which CBSE dropped the experts who set the Sociology and English paper from paper-setting panels. The Term 2 examination was conducted from 26 April 2022 for both Class 10 and 12 and ended on 24 May for Class 10 and 15 June for Class 12. The Class 12 results were declared on 22 July 2022, followed by Class 10 results on the same day.
== Release of GST-A1 as an indication of cellular necrosis == Increases in serum and urinary GST-A1 have been found in association with hepatocyte and renal proximal tubular necrosis respectively, and have potential for monitoring injury to these tissues.
Following its blockbuster success as a veterinary antiparasitic, another Merck scientist, Mohamed Aziz, collaborated with the World Health Organization to test the safety and efficacy of ivermectin against onchocerciasis in humans. They found it to be highly safe and effective, triggering Merck to register ivermectin for human use as "Mectizan" in France in 1987. A year later, Merck CEO Roy Vagelos agreed that Merck would donate all ivermectin needed to eradicate river blindness. In 1998, that donation would be expanded to include ivermectin used to treat lymphatic filariasis. Ivermectin earned the title of "wonder drug" for the treatment of nematodes and arthropod parasites. Ivermectin has been used safely by hundreds of millions of people to treat river blindness and lymphatic filariasis. Half of the 2015 Nobel Prize in Physiology or Medicine was awarded jointly to Campbell and Ōmura for discovering ivermectin, "the derivatives of which have radically lowered the incidence of river blindness and lymphatic filariasis, as well as showing efficacy against an expanding number of other parasitic diseases".
== Plot == Rick Rambis, best friend Luke, and other friends Anthony, "Pig Pen", Jenny, Lance and Stumpy, all live and work at a ski resort on Bull Mountain in Alaska. The mountain and resort were founded by Herbert "Papa" Muntz who stole the land from the Eskimos and loved to drink and ski at the same time until he died doing so. His son, Ted, took over the mountain and plans to sell it to wealthy Colorado ski resort tycoon John Majors. In addition to being friends, Rick has romantic designs on Jenny, but is held back as he is still getting over his ex, Anna, who mysteriously disappeared after 3 weeks of summer love in Mexico. After arriving at the mountain, John Majors plans to change the mountain name and turn the ski village into a first class resort but seeks Rick's help in getting his rowdy friends in line so as not to scare off his investors. John brings with him to the mountain his daughters, Inga, a Swiss ski bunny, and Anna, Rick's summer fling. After Anna's arrival, Rick then gets drunk and misses his date with Jenny. Later, Anna explains she left Rick in Mexico because she was already engaged to a doctor named Barry, who suffered an injury during the X Games, now a wheelchair user, and that Rick was the other man. Majors begins to make major changes to the town and mountain, such as changing the dive bar to an upscale club called Powder Room, removing the statue of Papa Muntz from the center of the town, and evicting some folks from their homes. Majors offers Rick a contract to be his new manager and Rick agrees on the condition that his friends all get to stay.
Sources: en.wikipedia.org
Scleral lenses are sometimes prescribed for cases of advanced or very irregular keratoconus; these lenses cover a greater proportion of the surface of the eye and hence can offer improved stability. Easier handling can find favor with people with reduced dexterity, such as the elderly.
===== MeSH D08.811.399.475 – intramolecular oxidoreductases (EC 5.3) ===== MeSH D08.811.399.475.200 – aldose-ketose isomerases MeSH D08.811.399.475.200.174 – autocrine motility factor MeSH D08.811.399.475.200.350 – glucose-6-phosphate isomerase MeSH D08.811.399.475.200.550 – mannose-6-phosphate isomerase MeSH D08.811.399.475.200.662 – neuroleukin MeSH D08.811.399.475.200.775 – triose-phosphate isomerase MeSH D08.811.399.475.400 – carbon-carbon double bond isomerases MeSH D08.811.399.475.400.700 – steroid isomerases MeSH D08.811.399.475.800 – sulfur-sulfur bond isomerases MeSH D08.811.399.475.800.550 – protein disulfide-isomerase MeSH D08.811.399.475.900 – thromboxane-a synthase
The Regional Centre for Biotechnology (RCB) is an autonomous institution of education, training and research established under the auspices of United Nations Educational, Scientific and Cultural Organization (UNESCO) and Department of Biotechnology (DBT, India). The Parliament has passed the Regional Centre for Biotechnology Bill, 2016 to provide statutory status to the existing institution. Dr. Arvind Sahu is the executive director of RCB.
For dinosterol derivatives, analysis is typically carried out by capillary gas chromatography and capillary gas chromatography-mass spectrometry. The mass spectrum of dinosterol as the TMS-ether shows characteristic ions at m/z 500 (M+), 429, 388, 359, 339 and 271. The base peak at m/z 69 is diagnostic for the A:2-unsaturated 23,24-dimethyl sidechain. Other purification techniques for dinosterol include various combinations of thin layer (TLC) and column chromatography with a variety of phases, AgNO3 impregnated Silica gel chromatography, normal phase-high performance liquid chromatography (NP-HPLC), and reversed phase-high performance liquid chromatography (RP-HPL).An alternative method has been proposed for purifying dinosterol from complex mixtures of sedimentary lipids for the purpose of hydrogen isotope analysis via gas chromatography-isotope ratio mass spectrometry (GC-IRMS). Reversed phase-high performance liquid chromatography (RP-HPLC) is used to separate dinosterol from structurally similar 4α-methyl sterols that co-elute on GC analysis, which allows for baseline resolution of dinosterol. For samples that contain a variety of 4a-methyl sterols, RP-HPLC purification can be preceded by NP-HPLC purification.
For services to School Governance and to Children and Young People with Special Educational Needs. Nigel Gavin Begg. Founder, Aspire Technology Solutions. For services to Digital and Technology Industry Growth in North East England. Lynda Janet Suzanne Bennett. For services to Hockey in Wales. Trudy Helen Berlet. Lately Lead Midwife for Bereavement Care, Worcestershire Acute Hospitals NHS Trust. For services to Midwifery. Professor Miriam Bernard. Professor Emerita, Social Gerontology, Keele University. For services to Ageing Research and to Older People. Jane Alison Betsworth. Headteacher, Millfields Community School, London Borough of Hackney. For services to Education. Dr. Sanjay Bhandari. Chair, Kick It Out. For services to Sport. Dr. Manav Bhavsar. Lately Clinical Lead, Critical Care. For services to Healthcare, particularly during Covid-19. Helen Binns. Manager, Families First Team, Leeds City Council. For services to Vulnerable People. Amanda Jayne Bird. Senior Supply Chain Coordinator, Leidos Europe Limited. For services to Defence Logistics. Zachary Birks. Team Leader, Ministry of Defence. For services to Defence. Professor Anthony John Bjourson. Emeritus Professor of Genomics and lately Director, Northern Ireland Centre for Stratified Medicine, Ulster University. For services to Higher Education and to Research. Anthony Grant Bloom. Chairman, Brighton and Hove Albion Football Club. For services to Association Football and to the community in Brighton. Anthony John Bloxham.
Sources: en.wikipedia.org
It acts on the growth hormone–releasing hormone receptor, a Gs-coupled receptor found on pituitary somatotroph cells. Activation raises cAMP and prompts pulsatile hormone release.
IGF-1 reflects growth hormone activity but changes slowly and can be measured from one sample. Growth hormone itself is pulsatile, which makes single measurements hard to interpret.
The receptor pathway is well described, but how individual responses vary and what governs long-term outcomes remain open questions. Reported differences across studies are often attributed to assay and population factors.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.